Prostate Cancer
In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis.
May 31, 2024
Unveiling Novel Double-Negative Prostate Cancer Subtypes Through Single-Cell RNA Sequencing Analysis.
May 31, 2024
AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production.
May 30, 2024
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series.
May 30, 2024
IL-38 promotes the development of prostate cancer.
May 29, 2024